- Home
- RXRX vs CNMD Comparison
RXRX vs CNMD Comparison
Compare RXRX & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CNMD
- Stock Information
- Founded
- RXRX 2013
- CNMD 1970
- Country
- RXRX United States
- CNMD United States
- Employees
- RXRX N/A
- CNMD N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RXRX Health Care
- CNMD Health Care
- Exchange
- RXRX Nasdaq
- CNMD Nasdaq
- Market Cap
- RXRX 2.6B
- CNMD 2.2B
- IPO Year
- RXRX 2021
- CNMD 1987
- Fundamental
- Price
- RXRX $7.21
- CNMD $67.38
- Analyst Decision
- RXRX Buy
- CNMD Buy
- Analyst Count
- RXRX 5
- CNMD 6
- Target Price
- RXRX $9.25
- CNMD $82.83
- AVG Volume (30 Days)
- RXRX 16.7M
- CNMD 402.4K
- Earning Date
- RXRX 02-25-2025
- CNMD 01-29-2025
- Dividend Yield
- RXRX N/A
- CNMD 1.18%
- EPS Growth
- RXRX N/A
- CNMD 127.53
- EPS
- RXRX N/A
- CNMD 4.22
- Revenue
- RXRX $65,184,000.00
- CNMD $1,288,116,000.00
- Revenue This Year
- RXRX $60.17
- CNMD $6.69
- Revenue Next Year
- RXRX $19.88
- CNMD $7.53
- P/E Ratio
- RXRX N/A
- CNMD $15.96
- Revenue Growth
- RXRX 37.64
- CNMD 10.23
- 52 Week Low
- RXRX $5.60
- CNMD $61.05
- 52 Week High
- RXRX $15.74
- CNMD $113.68
- Technical
- Relative Strength Index (RSI)
- RXRX 52.64
- CNMD 37.75
- Support Level
- RXRX $6.65
- CNMD $67.60
- Resistance Level
- RXRX $7.86
- CNMD $70.52
- Average True Range (ATR)
- RXRX 0.64
- CNMD 2.54
- MACD
- RXRX -0.00
- CNMD -0.43
- Stochastic Oscillator
- RXRX 66.32
- CNMD 7.64
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.